- Many ischemic stroke patients do not get tPA, which can decrease their chances for recovery.
- Blacks, Hispanics, women and “Stroke Belters” are less likely to get tPA.
- Patients treated in large, urban hospitals, stroke-certified hospitals and hospitals participating in the American Heart Association’s Get With The Guidelines®─Stroke program are more likely to get tPA.
- Patients with private insurance were more likely to receive tPA than those with Medicare.
Embargoed until 7:36 a.m. CT/8:36 a.m. ET, Thursday, Feb. 23, 2017
HOUSTON, Feb. 23, 2017 – Although tPA treatment for stroke is increasing over time, minorities, women and residents of 11 southeastern states that make up the “Stroke Belt” are left behind when it comes to receiving tPA, according to research presented at the American Stroke Association’s International Stroke Conference 2017.
Tissue plasminogen activator, or tPA, is the only treatment approved by the Food and Drug Administration for ischemic stroke, the most common kind of stroke. If administered within 4.5 hours of the first signs of stroke, tPA can dissolve the blood clot and restore blood flow to the affected part of the brain.
“Hospitals, governments and other organizations are undertaking efforts to increase the number of patients who receive tPA,” said Tracy Madsen, M.D., Sc.M., lead researcher and Assistant Professor of Emergency Medicine at Brown University in Rhode Island. “We wanted to see if these quality improvement efforts were making a difference.”
The study reviewed records from the National Inpatient Sample of 563,087 patients (median age 74) who had an ischemic stroke between 2005 and 2011. Overall, 3.8 percent of patients received tPA, with the number growing each year.
- Blacks were 38 percent less likely than whites to receive tPA.
- Hispanics were 25 percent less likely than whites to receive tPA.
- Women were 6 percent less likely than men to receive tPA.
- Those with private insurance were 29 percent more likely to receive tPA compared to those with Medicare.
- Residents of the “Stroke Belt” were 31 percent less likely than those living elsewhere to receive tPA.
Researchers also found that patients discharged from a designated stroke center or a hospital participating in the American Heart Association’s Get With The Guidelines®─Stroke program were more likely to receive tPA. Likewise, patients were more likely to receive tPA at large, urban, or teaching hospitals compared to hospitals discharged from small, rural, or non-teaching hospitals.
Madsen said that the growing number of hospitals participating in the Get With The Guidelines®─Stroke program and legislation requiring emergency services to take stroke patients to regional stroke centers are likely to increase the number of patients receiving tPA.
“Some previous studies have found that up to three-fourths of patients arrived after the time window for tPA had closed,” Madsen said. “Many patients across all groups do not arrive at the hospital in time, but this is particularly true for underrepresented minorities.”
An important limitation of the study data is that researchers could not determine why patients did not receive tPA. The study is also limited because we were not able to adjust for patient level factors such as time to arrival and other tPA exclusion criteria, stroke severity, patient education, and socioeconomic status. “More research needs to be done to help figure out why many patients do not receive tPA,” Madsen said.
“There is also a lot of work to do in the realm of stroke education so that patients recognize stroke symptoms and call EMS immediately,” Madsen said.
According to the American Heart Association’s Heart Disease and Stroke Statistical Update, 795,000 Americans have a stroke every year, causing almost 129,000 deaths. Residents of the Stroke Belt—Alabama, Arkansas, Georgia, Indiana, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee and Virginia—suffer even higher rates of stroke and stroke death.
The National Inpatient Sample is the largest publicly available database of inpatient health care in the U.S.
Coauthors are Shannon Melluzo, B.A.; Charles R. Wira III, M.D.; Zainab Magdon-Ismail, Ed.M., M.P.H.; David Day, B.S.; and Toby I. Gropen, M.D.
Author disclosures are on the abstract.
The study was funded by the American Heart Association/American Stroke Association Founders Affiliate, and the Northeast Cerebrovascular Consortium.
- Any available downloadable video/audio interviews, B-roll, animation, graphics, and images related to this news release are on the right column of the release link http://newsroom.heart.org/news/many-stroke-patients-do-not-receive-life-saving-therapy?preview=13bffffcc15f8d35a03f7314a3b1eded.
- Spanish Release
- Video clips with researchers/authors of the studies will be added to the release link as available.
- Acute Ischemic Stroke Treatment Toolkit
- Cost of effective stroke clot-busting drug outpaces reimbursement
- Follow news from ASA International Stroke Conference 2017 via Twitter @HeartNews #ISC17.
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
For Media Inquiries and ASA Spokesperson Perspective:
AHA/ASA News Media in Dallas: (214) 706-1173
AHA/ASA News Media Office, Feb. 22-24,
George R. Brown Convention Center: (713) 853-8406
For Public Inquiries: (800) AHA-USA1 (242-8721)
Life is why, science is how . . . we help people live longer, healthier lives.